Fri, Dec 26, 2014, 4:26 AM EST - U.S. Markets open in 5 hrs 4 mins

Recent

% | $
Quotes you view appear here for quick access.

Immune Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • schantz_daniel schantz_daniel Jun 19, 2012 11:24 AM Flag

    New report on Epicept. $$

    The cash received from this transaction together with the savings from future expenses, after making a partial prepayment on EpiCept's existing term loan with MidCap Financial LLC of approximately $0.8 million, will enable EpiCept to operate into the (fourth quarter 2012) without further financing.the most in important here is the trial AmiKetâ„¢ . long time inverter in this crappy company need sell at $2.50 just to break even so im hostage right now but if amiket passes in america its could jump to $15.00 big pharma likes new painkillers people always get addicted to them and they will pay top dollar for it peace out.

 
IMNP
1.89+0.02(+1.07%)Dec 24 12:58 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Virgin America Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST
Gilead Sciences Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST
Vanda Pharmaceuticals, Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST